Corrigan Oonagh
Centre for Family Research, Faculty of Social and Political Sciences University of Cambridge.
Sociol Health Illn. 2003 Nov;25(7):768-92. doi: 10.1046/j.1467-9566.2003.00369.x.
Informed consent is increasingly heralded as an ethical panacea, a tool to counter autocratic and paternalistic medical practices. Debate about the implementation of informed consent is constricted and polarised, centring on the right of individuals to be fully informed and to freely choose versus an autocratic, paternalistic practice that negates individual choice. A bioethical framework, based on a principle-led form of reductive/deductive reasoning, dominates the current model of informed consent. Such a model tends to abstract the process of consent from its clinical and social setting. By fleshing out the social process involved whe patients and healthy volunteer subjects consent to take part in clinical drug trials, this paper attempts to address the problem arising from the current 'empty ethics' model. My arguments are substantiated by qualitative interview data drawn from a study I conducted on the process of consent as experienced by participants in clinical drug trials.
知情同意越来越被视为一种道德万灵药，一种对抗专制和家长式医疗行为的工具。关于知情同意实施的辩论受到限制且两极分化，主要集中在个人充分知情并自由选择的权利与否定个人选择的专制、家长式做法之间的对立。一个基于原则主导的还原/演绎推理形式的生物伦理框架主导着当前的知情同意模式。这种模式往往将同意过程从其临床和社会背景中抽象出来。通过详细阐述患者和健康志愿者受试者同意参与临床药物试验时所涉及的社会过程，本文试图解决当前“空洞伦理”模式所产生的问题。我的论点得到了我对临床药物试验参与者同意过程进行研究所得出的定性访谈数据的支持。
